TipRanks
Go Ultimate55% OFF

Yvonne Greenstreet Insider Profile

4 Followers

Yvonne Greenstreet, CEO, Director at Alnylam Pharma, holds 96.21K shares in Alnylam Pharma (Ticker: ALNY), holds 13.25K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 1.06K shares in Moelis (Ticker: MC).

Yvonne Greenstreet's Trading History

ALNY
Alnylam Pharma
Sep 22, 2026CEO, DirectorUninformative Buy―$15.87M
PCRX
Pacira Pharmaceuticals
Jun 08, 2022DirectorUninformative Buy―$482.06K
MC
Moelis
Nov 16, 2018DirectorUninformative Buy―$62.05K

You May Also Like

Yvonne Greenstreet insider profile FAQ

What is the percentage of profitable transactions made by Yvonne Greenstreet?
The percentage of profitable transactions made by Yvonne Greenstreet is 54%.
What is the average return per transaction made by Yvonne Greenstreet?
The average return per transaction made by Yvonne Greenstreet is 4.20%.
What stocks does Yvonne Greenstreet hold?
Yvonne Greenstreet holds: ALNY, PCRX, MC stocks.
What was Yvonne Greenstreet's most profitable transaction?
Yvonne Greenstreet’s most profitable transaction was an Informative Sell of ALNY stock on January 14, 2026. The return on the trade was 55.00%.
What is Yvonne Greenstreet's role in Alnylam Pharma?
Yvonne Greenstreet's role in Alnylam Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.